Kaplan-Meyer analyses indicated that high sPD-1 concentrations (>11.14 pg/mL) predict shorter PFS times, with a median of 25.0 months for glioma patients (log-rank p<0.001) (Figure 4E). Here, HOXD13 is linked to central nervous system cancer.